DOCK 4 Antibodies

Santa Cruz Biotechnology features a diverse variety of DOCK 4 monoclonal antibodies for investigating DOCK 4 protein function. DOCK 4 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).DOCK 4, or Dedicator of Cytokinesis 4, belongs to the DOCK family of proteins that regulate cytoskeletal dynamics and cell migration. DOCK 4 activates small GTPases, which control various cellular processes, including cell signaling and motility. Research has shown DOCK 4's significance in cancer metastasis and diseases involving altered cell movement. Understanding DOCK 4's molecular mechanisms can provide valuable insights into disease progression and potential therapeutic strategies. Investigating DOCK 4's role in cell migration pathways may reveal new approaches for treating metastatic conditions. Current research focuses on understanding how DOCK 4 influences cellular behavior in both normal and pathological states. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of DOCK 4's role in health and disease.